GoodRx Holdings, Inc. (NASDAQ:GDRX – Get Rating) saw a significant decrease in short interest in March. As of March 15th, there was short interest totalling 11,050,000 shares, a decrease of 30.9% from the February 28th total of 15,980,000 shares. Approximately 16.5% of the company’s shares are short sold. Based on an average trading volume of […]
GoodRx (NASDAQ:GDRX – Get Rating) had its price objective cut by Credit Suisse Group from $27.00 to $22.00 in a research note released on Thursday, Marketbeat.com reports. They currently have a neutral rating on the stock. Other research analysts also recently issued reports about the stock. Jefferies Financial Group initiated coverage on shares of GoodRx […]
GoodRx (NASDAQ:GDRX – Get Rating) had its target price lowered by research analysts at Morgan Stanley from $41.00 to $19.00 in a report released on Wednesday, Analyst Ratings Network reports. The firm presently has an “equal weight” rating on the stock. Morgan Stanley’s target price would suggest a potential upside of 11.11% from the company’s […]
GoodRx (NASDAQ:GDRX – Get Rating) had its target price cut by stock analysts at SVB Leerink from $49.00 to $33.00 in a note issued to investors on Tuesday, The Fly reports. SVB Leerink’s target price would indicate a potential upside of 94.00% from the company’s previous close. Several other research firms also recently commented on […]